Literature DB >> 23299851

Therapeutic advantage in selective ligament augmentation for partial tears of the anterior cruciate ligament: results in an animal model.

Yutaka Mifune1, Shusuke Ota, Koji Takayama, Yuichi Hoshino, Tomoyuki Matsumoto, Ryosuke Kuroda, Masahiro Kurosaka, Freddie H Fu, Johnny Huard.   

Abstract

BACKGROUND: As a result of recent studies describing the double-bundle anterior cruciate ligament (ACL), selected ACL augmentation procedures, either anteromedial (AM) or posterolateral (PL), have been introduced as the treatment of choice for partial ACL ruptures. The preserved mechanoreceptor and vascularity of the remnant ACL are considered to provide additional biological benefits. Although enhanced knee joint proprioception in ACL augmented patients has been previously reported, there is no study assessing biological healing advantages of the graft after the ACL augmentation procedure. HYPOTHESIS: Selected ACL augmentation for partial tears can accelerate the healing process of the grafted tendon, which promotes better biomechanical recovery of the tendon, compared with conventional ACL reconstruction of complete tears. STUDY
DESIGN: Controlled laboratory study.
METHODS: Two rat models were established in this study: an ACL augmentation partial tear model and conventional ACL reconstruction for a complete tear. Biological assessments of cellularity and angiogenesis were measured by hematoxylin and eosin staining and immunostaining, respectively. Additionally, rat-specific type III collagen and α-smooth muscle actin were evaluated by immunohistochemical staining to analyze the healing process, whereas anti-rat neurofilament antigen was assessed to examine proprioceptive recovery. Biological assessments of the augmented and reconstructed grafts were conducted postoperatively at week 2, whereas biomechanical testing was performed postoperatively at week 8.
RESULTS: An increase in cellularity and angiogenesis was observed in the augmented grafts compared with the conventionally reconstructed grafts. Also, increased amounts of rat-specific type III collagen, α-smooth muscle actin, and anti-rat neurofilament antigen were expressed in the augmented grafts. Biomechanical testing showed that failure to load was significantly higher in the augmentation group compared with the conventional reconstruction group (augmentation, 15.9 ± 1.0; reconstruction, 7.0 ± 1.3; P < .01). CLINICAL RELEVANCE: Selected ACL augmentation could be a good choice for the repair of partial ACL injury by preserving the uninjured portion of the ACL, which in turn could maintain the anatomic position of the ligament and its biomechanical function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299851     DOI: 10.1177/0363546512471614

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  20 in total

1.  Comparison of double-bundle anterior cruciate ligament (ACL) reconstruction and single-bundle reconstruction with remnant pull-out suture.

Authors:  Seong Hwan Kim; Young Bok Jung; Min Ku Song; Sang Hak Lee; Ho Joong Jung; Han Jun Lee; Hyoung Seok Jung; Hawa-Tahir Siti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-07-27       Impact factor: 4.342

2.  Anterior Cruciate Ligament Reconstruction and Preservation: The Single-Anteromedial Bundle Biological Augmentation (SAMBBA) Technique.

Authors:  Bertrand Sonnery-Cottet; Benjamin Freychet; Colin G Murphy; Barbara H B Pupim; Mathieu Thaunat
Journal:  Arthrosc Tech       Date:  2014-11-24

3.  Clinical outcomes and biomechanical analysis of posterolateral bundle augmentation in patients with partial anterior cruciate ligament tears.

Authors:  Takehiko Matsushita; Ryosuke Kuroda; Yuichiro Nishizawa; Daisuke Araki; Yuichi Hoshino; Kanto Nagai; Tomoyuki Matsumoto; Masahiro Kurosaka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-07-11       Impact factor: 4.342

4.  Behind-remnant arthroscopic observation and scoring of femoral attachment of injured anterior cruciate ligament.

Authors:  Takeshi Muneta; Hideyuki Koga; Tomomasa Nakamura; Masafumi Horie; Toshifumi Watanabe; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-03-13       Impact factor: 4.342

5.  Updates in biological therapies for knee injuries: anterior cruciate ligament.

Authors:  Carlos Eduardo da Silveira Franciozi; Sheila Jean McNeill Ingham; Guilherme Conforto Gracitelli; Marcus Vinicius Malheiros Luzo; Freddie H Fu; Rene Jorge Abdalla
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

6.  Anatomic and non-anatomic anterior cruciate ligament posterolateral bundle augmentation affects graft function.

Authors:  Can Yapici; Levent Surer; Kenan Keklikci; Dongliang Shi; Soheil Sabzevari; Monica A Linde; Patrick Smolinski; Freddie H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-07-29       Impact factor: 4.342

Review 7.  Selective bundle versus complete anterior-cruciate ligament reconstruction: A systematic review and meta-analysis.

Authors:  Mark Hx Yeo; Shawn Js Seah; Cheryl Gatot; Andy Yew; Denny Lie
Journal:  J Orthop       Date:  2022-07-31

8.  Effect of a new remnant-preserving technique with anatomical double-bundle anterior cruciate ligament reconstruction on MRI-based graft maturity: a comparison cohort study.

Authors:  Hiroki Shimodaira; Keiji Tensho; Suguru Koyama; Tomoya Iwaasa; Daiki Kumaki; Kazushige Yoshida; Hiroshi Horiuchi; Jun Takahashi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-10-01       Impact factor: 4.114

Review 9.  Current trends in anterior cruciate ligament reconstruction.

Authors:  Ha Sung Kim; Jong Keun Seon; Ah Reum Jo
Journal:  Knee Surg Relat Res       Date:  2013-11-29

10.  Posterolateral Bundle Reconstruction With Anteromedial Bundle Remnant Preservation in ACL Tears: Clinical and MRI Evaluation of 39 Patients With 24-Month Follow-up.

Authors:  Bertrand Sonnery-Cottet; Rachad Zayni; Jacopo Conteduca; Pooler Archbold; Thierry Prost; Yannick Carrillon; Julien Clechet; Mathieu Thaunat
Journal:  Orthop J Sports Med       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.